Category: Drug Discovery
Drug Discovery market research reports by Frost & Sullivan
-
Engineered Antibody Therapeutics for Cancer
Engineered Antibody Therapeutics for Cancer Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limi ... Read More
-
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024–2028
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024–2028 GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID ... Read More
-
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities The Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials As global clinical pipelines witness a surge in complex novel therapies, there is a general inclinati ... Read More
-
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023 More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid- ... Read More
-
Global Precision Cardiometabolic Growth Opportunities
Global Precision Cardiometabolic Growth Opportunities Cardiometabolic diseases, including cardiovascular disease (which encompasses coronary artery diseases, chronic/congestive heart failure, stroke, and hypertension), type 2 diabetes, and obesity, have been increasing globally. As a result, the hea ... Read More
-
Global Precision Oncology Market - Trends and Growth Opportunities
Global Precision Oncology Market - Trends and Growth Opportunities The procedure for accurately identifying a biomarker correlation based on a patient’s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional ... Read More
-
Generative Artificial Intelligence Growth Opportunities in the Healthcare and Life Science Industry
Generative Artificial Intelligence Growth Opportunities in the Healthcare and Life Science Industry Possibilities Exist to Adapt Large Language Models and Reinvent Enterprise Functions This project provides an overview of the effects of generative AI (Gen AI) on the healthcare and life science indus ... Read More
-
Growth Opportunities in the Global Digital Therapeutics Market
Growth Opportunities in the Global Digital Therapeutics Market Preventive Care and Market Access Strategies Spur New Growth Opportunities This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global digital therapeutics (DTx) market and highlights key growth ... Read More
-
Global Liquid Dosage Excipients Growth Opportunities
Global Liquid Dosage Excipients Growth Opportunities Demand for Patient-centric Parenteral Formulation Accelerates Growth Potential The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major region ... Read More
-
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities Right Shoring and Targeted Therapeutics Create Future Growth CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecul ... Read More
-
Emerging Landscape of Targeted Protein Degradation Therapeutics
Emerging Landscape of Targeted Protein Degradation Therapeutics Rapid Technology Advances Bolster a Robust Therapeutic Pipeline This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various disease ... Read More
-
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Disruptive Technology Advances in SynBio Foster a Thriving Stakeholder Ecosystem and Accelerate Biopharma Developments The SynBio field has evolved well over the past two decades, with significant technology disruptions le ... Read More
-
Growth Indicators for Technology-enabled Drug Discovery
Growth Indicators for Technology-enabled Drug Discovery Innovative Business Models across the TEDD Landscape Support the Emergence of AI-powered Therapeutics Providers As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules ... Read More
-
Technology Innovations and Growth Opportunities in Inhaled Therapeutics
Technology Innovations and Growth Opportunities in Inhaled Therapeutics Nanoparticle-based Formulation to Drive Transformational Growth Across Inhaled Vaccines and Monoclonal Antibodies Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (in ... Read More
-
Global Contract Research Organization (CRO) Growth Opportunities
Global Contract Research Organization (CRO) Growth Opportunities The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapie ... Read More
-
Growth Opportunities for Digital Biomarkers in Drug Development
Growth Opportunities for Digital Biomarkers in Drug Development Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data ... Read More
-
Global RNA Therapeutics Growth Opportunities
Global RNA Therapeutics Growth Opportunities Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” ... Read More
-
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022 Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the i ... Read More
-
Global Cancer Survivorship Care Growth Opportunities
Global Cancer Survivorship Care Growth Opportunities The global cancer survivorship care market has gained significance due to improvements in cancer treatment and the rising cancer survival rates. The availability of reimbursement policies in the United States favors the cancer survivorship care ma ... Read More
-
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug developmen ... Read More
Research Assistance
